Your browser is no longer supported. Please, upgrade your browser.
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E16.56 EPS (ttm)3.32 Insider Own0.04% Shs Outstand5.61B Perf Week-1.38%
Market Cap311.74B Forward P/E8.94 EPS next Y6.15 Insider Trans-15.14% Shs Float5.61B Perf Month-6.55%
Income18.90B PEG0.85 EPS next Q0.86 Inst Own67.60% Short Float1.05% Perf Quarter32.44%
Sales69.34B P/S4.50 EPS this Y-33.10% Inst Trans0.20% Short Ratio1.39 Perf Half Y36.86%
Book/sh13.49 P/B4.07 EPS next Y45.28% ROA11.60% Target Price58.79 Perf Year49.73%
Cash/sh5.23 P/C10.50 EPS next 5Y19.50% ROE27.60% 52W Range33.36 - 61.71 Perf YTD-6.94%
Dividend1.60 P/FCF14.75 EPS past 5Y2.20% ROI7.60% 52W High-10.95% Beta0.71
Dividend %2.91% Quick Ratio1.20 Sales past 5Y-3.00% Gross Margin65.40% 52W Low64.72% ATR1.83
Employees78500 Current Ratio1.40 Sales Q/Q134.40% Oper. Margin28.30% RSI (14)46.80 Volatility2.46% 3.10%
OptionableYes Debt/Eq0.53 EPS Q/Q782.70% Profit Margin27.70% Rel Volume0.63 Prev Close55.54
ShortableYes LT Debt/Eq0.48 EarningsFeb 08 BMO Payout45.20% Avg Volume42.27M Price54.95
Recom- SMA20-4.74% SMA502.06% SMA20022.68% Volume26,832,026 Change-1.06%
Jan-05-22Upgrade BofA Securities Neutral → Buy $59 → $70
Jan-03-22Reiterated Bernstein Mkt Perform $44 → $65
Dec-20-21Reiterated Cowen Outperform $56 → $70
Dec-17-21Initiated Goldman Neutral $51
Dec-13-21Upgrade UBS Neutral → Buy $52 → $60
Dec-09-21Initiated Wells Fargo Overweight $60
Nov-19-21Initiated BMO Capital Markets Outperform $60
Jul-27-21Resumed Truist Buy $43
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-17-22 12:53PM  
11:38AM  
10:39AM  
10:37AM  
09:44AM  
09:20AM  
09:04AM  
08:25AM  
08:16AM  
07:25AM  
06:29AM  
06:26AM  
05:55AM  
04:00AM  
01:03AM  
Jan-16-22 11:34PM  
11:31AM  
09:31AM  
06:47AM  
05:55AM  
Jan-15-22 01:30PM  
06:03AM  
Jan-14-22 05:38PM  
04:14PM  
03:46PM  
03:30PM  
02:39PM  
02:12PM  
01:38PM  
01:25PM  
11:52AM  
11:34AM  
11:19AM  
10:18AM  
10:07AM  
09:38AM  
09:38AM  
05:24AM  
05:04AM  
03:30AM  
Jan-13-22 09:38PM  
06:17PM  
03:56PM  
01:43PM  
01:38PM  
01:38PM  
11:34AM  
10:29AM  
10:25AM  
08:48AM  
08:01AM  
07:00AM  
05:52AM  
05:41AM  
05:06AM  
04:44AM  
03:07AM  
02:09AM  
Jan-12-22 11:59PM  
06:01PM  
05:45PM  
05:38PM  
05:38PM  
05:22PM  
04:57PM  
03:42PM  
02:52PM  
12:07PM  
11:10AM  
11:01AM  
10:45AM  
10:42AM  
10:30AM  
09:35AM  
08:34AM  
07:29AM  
06:45AM  
03:00AM  
Jan-11-22 05:02PM  
04:33PM  
03:46PM  
03:33PM  
03:25PM  
01:53PM  
01:49PM  
01:38PM  
01:38PM  
11:18AM  
10:32AM  
10:31AM  
10:31AM  
10:30AM  
10:25AM  
10:24AM  
10:22AM  
10:04AM  
10:00AM  
09:49AM  
08:00AM  
07:47AM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dolsten MikaelPresident R&DDec 17Option Exercise30.1771,1872,147,712351,637Dec 21 06:31 PM
BOURLA ALBERTChairman & CEODec 17Option Exercise26.73123,0553,289,547246,444Dec 21 06:03 PM
JOHNSON RADY AExecutive Vice PresidentDec 03Sale53.4219,0001,015,04255,844Dec 06 05:18 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentDec 02Sale54.2641,3602,244,19487,280Dec 06 05:18 PM
SUSMAN SALLYExecutive Vice PresidentNov 26Sale54.5244,3082,415,57889,575Nov 30 04:30 PM
LANKLER DOUGLAS MExecutive Vice PresidentNov 26Sale54.3740,0002,174,78666,317Nov 30 04:30 PM
Hwang AngelaGroup PresidentNov 12Sale49.6026,1701,298,0021Nov 15 05:32 PM
Dolsten MikaelPresident R&DNov 11Option Exercise25.13199,5485,014,926339,506Nov 15 05:40 PM
Dolsten MikaelPresident R&DNov 11Sale50.2959,6643,000,647279,842Nov 15 05:40 PM
YOUNG JOHN DGroup PresidentNov 11Sale50.06150,0007,508,732312,704Nov 12 06:08 PM
DAMICO JENNIFER B.SVP & ControllerAug 13Sale48.301,66180,2269,769Aug 16 08:12 PM
DAMICO JENNIFER B.SVP & ControllerJul 30Sale42.862,500107,15011,430Aug 02 07:02 PM
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM